Drug‐induced hperpigemntation: a systematic review
Author:
- 8 May 2013
- journal article
- research article
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 11 (7) , 644-651
Abstract
Summary: Background: Acquired hyperpigmentation of the skin is sometimes interpreted as an adverse effect of drugs. Systematic studies are rare in the literature; predominantly case reports have been published. The present review provides evaluates the evidence for a causal relation.Methods: The reports on a relationship between hyperpigmentation and drugs from 1970 until June 2012 found in MEDLINE and EMBASE were rated according to the SIGN grading system for clinical studies. In this system, the grade of evidence of each report is rated. The highest grade of evidence for each drug is cited.Results: 306 publications were included. They were predominantly case reports; only a small number of case series was available. Only very few case‐control‐studies and randomized controlled trials (RCT) were found. For the majority of drugs, there was a low level of evidence for a causal relationship in drug‐induced hyperpigmentation. A causal relationship is likely only for prostaglandins, minocycline, phenothiazine, nicotine, and antimalarial drugs.Conclusions: There is little evidence for drug‐induced hyperpigmentation. A causal relationship appears liklely only for a limited number of drugs.Keywords
This publication has 19 references indexed in Scilit:
- Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trialClinical Ophthalmology, 2012
- Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trialsClinical Ophthalmology, 2011
- Five-year, Multicenter Safety Study of Fixed-combination Latanoprost/Timolol (Xalacom) for Open-angle Glaucoma and Ocular HypertensionJournal of Glaucoma, 2011
- Antimalarial cutaneous side effects: a study in 209 usersCutaneous and Ocular Toxicology, 2010
- A review of preserved and preservative-free prostaglandin analogues for the treatment of open-angle glaucoma and ocular hypertensionDrugs of Today, 2010
- A Study of Histopathological Features of Latanoprost-Treated Irides With or Without Darkening Compared With Non–Latanoprost-Treated IridesJAMA Ophthalmology, 2008
- Association of lip pigmentation with smoking and gingival melanin pigmentationOral Diseases, 2007
- Prevention of Dermatologic Side Effects of Bimatoprost 0.03% Topical TherapyAmerican Journal of Ophthalmology, 2006
- Analysis of irises with a latanoprost-induced change in iris colorAmerican Journal of Ophthalmology, 2004
- CUTANEOUS HYPERPIGMENTATION CAUSED BY SYSTEMIC DRUGSInternational Journal of Dermatology, 1992